ANNEMARIE ARMIJOS: Open Payments
NPI 1598251316 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 41 payments from 19 companies in 2025. Trend: 2023 $338 · 2024 $1,843 · 2025 $947
Food & beverage: $847Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $158 |
| Astellas Pharma US Inc | 3 | $133 |
| Daiichi Sankyo Inc. | 4 | $110 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| ABBVIE INC. | 2 | $64 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $58 |
| Janssen Biotech, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Stemline Therapeutics Inc. | 1 | $34 |
| Iovance Biotherapeutics, Inc. | 1 | $33 |
Products named: KISQALI, Enhertu, KEYTRUDA, VENCLEXTA, ZYNLONTA, TALVEY, Orserdu, LUTATHERA.
Industry payments across VA — which companies pay providers there.
